MRC Molecular Haematology Unit
At the MRC Molecular Haematology Unit, we aim to understand how stem cells produce mature blood cells in a healthy context, and how this process is perturbed in common blood disorders.
MRC MHU includes 14 research teams with over 140 scientists who share a common goal, to improve the prognosis of patients with inherited and acquired blood diseases.
This is an exciting time for the field of haematology. The -omics revolution is enabling scientists to unravel the complex molecular processes governing biology at unprecedented speed. At the MRC MHU our teams are committed to applying such cutting-edge techniques to better understand the molecular basis of blood diseases, and to develop treatments to improve the lives of patients. - Professor KJ Patel
Latest publications
Paediatric traumatic brain injury: clinical presentation, treatment approaches, management strategies, and outcomes. Insights from the CENTER-TBI study
Journal article
Graziano F. et al, (2026), Journal of Anesthesia Analgesia and Critical Care, 6
NMR metabolomics and glycomics for cancer detection in patients with non-specific symptoms: a prospective observational cohort study.
Journal article
Kacerova T. et al, (2026), EBioMedicine, 131
Transmission ratio distortion of NF1 mutant alleles in familial Neurofibromatosis type 1.
Journal article
Pei Y. et al, (2026), Genet Med
Concordance of genetic determinants of acute coronary artery disease between European and Chinese populations.
Journal article
Edris A. et al, (2026), Gigascience